Page last updated: 2024-10-17

aminocaproic acid and Antibody Deficiency Syndrome

aminocaproic acid has been researched along with Antibody Deficiency Syndrome in 1 studies

Aminocaproic Acid: An antifibrinolytic agent that acts by inhibiting plasminogen activators which have fibrinolytic properties.
6-aminohexanoic acid : An epsilon-amino acid comprising hexanoic acid carrying an amino substituent at position C-6. Used to control postoperative bleeding, and to treat overdose effects of the thrombolytic agents streptokinase and tissue plasminogen activator.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Van Dellen, RG1

Other Studies

1 other study available for aminocaproic acid and Antibody Deficiency Syndrome

ArticleYear
Long-term treatment of C1 inhibitor deficiency with epsilon-aminocaproic acid in two patients.
    Mayo Clinic proceedings, 1996, Volume: 71, Issue:12

    Topics: Adult; Aminocaproic Acid; Angioedema; Antifibrinolytic Agents; Complement C1 Inactivator Proteins; F

1996